28/29
(97%) Patients were Asymptomatic* from
Peripheral Neuropathy within 8
Months Following Dose Dense
Abraxane at 260 mg/m2
* Grade 0 or 1 per NCI CT
CAE
Proportion Asymptomatic*
Months
u59% asymptomatic at end of 4 cycle RX
u75% 2 months
p Rx
u97% 8 months
p Rx
29 Patients Treated with Abraxane